Shingrix vs Arexvy
A side-by-side look at two vaccine medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Shingrix | US Arexvy |
|---|---|---|
| Generic name | zoster vaccine recombinant, adjuvanted Unverified catalogue summary (Generic name) for Shingrix in US; not checked against current local product information. | respiratory syncytial virus vaccine, recombinant, adjuvanted Unverified catalogue summary (Generic name) for Arexvy in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Shingrix in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Arexvy in US; not checked against current local product information. |
| Treats | Shingles prevention Unverified catalogue summary (Treats) for Shingrix in US; not checked against current local product information. | Prevention of RSV lower respiratory tract disease in adults 60+ and adults 18–59 at increased risk Unverified catalogue summary (Treats) for Arexvy in US; not checked against current local product information. |
| Category | Vaccine Unverified catalogue summary (Category) for Shingrix in US; not checked against current local product information. | Vaccine Unverified catalogue summary (Category) for Arexvy in US; not checked against current local product information. |
| Manufacturer | GSK Unverified catalogue summary (Manufacturer) for Shingrix in US; not checked against current local product information. | GSK Unverified catalogue summary (Manufacturer) for Arexvy in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Shingrix in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Arexvy in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Shingrix in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Arexvy in US; not checked against current local product information. |
| Est. TV ad spend | $150M | $110M |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Shingrix in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Arexvy in US; not checked against current local product information. |
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Shingrix or Arexvy better?
This directory does not compare clinical effectiveness or safety. Listing Shingrix and Arexvy together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Shingrix and Arexvy?
The table shows catalogue identification and estimated advertising information for Shingrix and Arexvy, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Shingrix has the larger estimated TV advertising budget of the two.